![Fergus Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 14 422 $ au 31/05/2026
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc.
Previously, he worked as the Managing Director at Ff Consulting Ltd. from 2014 to 2018.
He also served as the Head-Business Development at Oncomark Ltd. from 2016 to 2018.
Mr. Fleming completed his undergraduate degree at the National University of Ireland Galway.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RENALYTIX PLC 0,14 % | 20/12/2024 | 594 481 ( 0,14 % ) | 14 422 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RENALYTIX PLC | Directeur Technique/Scientifique/R&D | 15/03/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
Ff Consulting Ltd. | Directeur Général | 01/11/2018 |
Oncomark Ltd.
 Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Corporate Officer/Principal | 01/10/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renalytix Plc
 Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
Ff Consulting Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
